Literature DB >> 23358989

Metformin and breast cancer risk.

Sara Gandini, Aliana Guerrieri-Gonzaga, Matteo Puntoni, Andrea Decensi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23358989     DOI： 10.1200/JCO.2012.46.3596

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

Review 1.  Effects of sulfonylureas on tumor growth: a review of the literature.

Authors:  Giulia Pasello; Loredana Urso; Pierfranco Conte; Adolfo Favaretto
Journal:  Oncologist       Date:  2013-09-16

2.  Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b.

Authors:  Reema S Wahdan-Alaswad; Dawn R Cochrane; Nicole S Spoelstra; Erin N Howe; Susan M Edgerton; Steven M Anderson; Ann D Thor; Jennifer K Richer
Journal:  Horm Cancer       Date:  2014-09-12       Impact factor: 3.869

3.  Metformin Induces Cell Cycle Arrest, Reduced Proliferation, Wound Healing Impairment In Vivo and Is Associated to Clinical Outcomes in Diabetic Foot Ulcer Patients.

Authors:  Fatima Ochoa-Gonzalez; Alberto R Cervantes-Villagrana; Julio C Fernandez-Ruiz; Hilda S Nava-Ramirez; Adriana C Hernandez-Correa; Jose A Enciso-Moreno; Julio E Castañeda-Delgado
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

4.  Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients.

Authors:  Wei-Ru Cho; Chih-Chi Wang; Meng-Yun Tsai; Chen-Kai Chou; Yueh-Wei Liu; Yi-Ju Wu; Ming-Tsung Lin; Kuang-Den Chen; Ching-Hui Chuang; Pao-Yuan Huang; Tsung-Hui Hu; Ming-Chao Tsai
Journal:  PLoS One       Date:  2021-03-04       Impact factor: 3.240

Review 5.  Willin/FRMD6: A Multi-Functional Neuronal Protein Associated with Alzheimer's Disease.

Authors:  Doris Chen; Wanjia Yu; Laura Aitken; Frank Gunn-Moore
Journal:  Cells       Date:  2021-11-04       Impact factor: 6.600

6.  Metformin suppresses breast cancer growth via inhibition of cyclooxygenase-2.

Authors:  Bin Shi; Xinyu Hu; Huimin He; Wenzheng Fang
Journal:  Oncol Lett       Date:  2021-06-23       Impact factor: 2.967

7.  C-Terminal Binding Protein: A Molecular Link between Metabolic Imbalance and Epigenetic Regulation in Breast Cancer.

Authors:  Jung S Byun; Kevin Gardner
Journal:  Int J Cell Biol       Date:  2013-05-20

8.  Association of Metformin Use With Cancer-Specific Mortality in Hepatocellular Carcinoma After Curative Resection: A Nationwide Population-Based Study.

Authors:  Young-Seok Seo; Yun-Jung Kim; Mi-Sook Kim; Kyung-Suk Suh; Sang Bum Kim; Chul Ju Han; Youn Joo Kim; Won Il Jang; Shin Hee Kang; Ha Jin Tchoe; Chan Mi Park; Ae Jung Jo; Hyo Jeong Kim; Jin A Choi; Hyung Jin Choi; Michael N Polak; Min Jung Ko
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

9.  Metformin suppresses proliferation and invasion of drug-resistant breast cancer cells by activation of the Hippo pathway.

Authors:  Jie Liu; Juan Li; He Chen; Ruiqi Wang; Pingping Li; Yi Miao; Peijun Liu
Journal:  J Cell Mol Med       Date:  2020-04-12       Impact factor: 5.310
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.